Repeated Sprint Training in Normobaric Hypoxia
Three Sessions of Repeated Sprint Training in Normobaric Hypoxia With 48-Hour Interval Improves Repeated Sprint Performance Indices
1 other identifier
interventional
24
1 country
1
Brief Summary
The aim of the current study was to examine the effects of 3-session repeated sprint training performed in a normobaric hypoxic condition with 48-hour rest intervals on sprint performance indices, arterial oxygen saturation (SpO2) and rating of perceived exertion (RPE) scores. Twenty-four moderately-trained males participated in this study voluntarily basis. This study was conducted on single-blind placebo-controlled design. Participants were divided into three groups as follows; normobaric hypoxia (3420 m; HYP), normobaric normoxia (162 m; PLA) and control group (CON). HYP and PLA groups subjected to 3 repeated sprint training session (4 set x 5 x 5 s sprints with 30 s recovery and 5 min rest between the sets) in normobaric hypoxia or normoxia condition. Pre- and pos-test were conducted 72 hours before and after the training intervention period. All the training and testing sessions performed in cycle ergometer. There were no detected significant time and condition interaction in the variables; relative peak power output (PPO), mean power output (MPO), percentage of sprint decrement score (Sdec%) and RPE observed in the scope of pre- and post-test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2022
CompletedFirst Submitted
Initial submission to the registry
July 15, 2023
CompletedFirst Posted
Study publicly available on registry
August 1, 2023
CompletedAugust 1, 2023
July 1, 2023
24 days
July 15, 2023
July 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Relative Peak Power Output
Relative peak power output (as newton meter) produced during the repeated cycling sprint tests by the participant in the scope of pre and post tests were recorded and assessed via Lode Cycling Ergometer Software. The total intervention period was 11 days from pre to post test. The change evaluated from pre to post test.
11 days
Relative Mean Power Output
Relative mean power output (as newton meter) produced during the repeated cycling sprint tests by the participant in the scope of pre and post tests were recorded and assessed via Lode Cycling Ergometer Software. The total intervention period was 11 days from pre to post test. The change evaluated from pre to post test.
11 days
Percentage of Sprint Decrement Score
Percentage of sprint decrement score calculated via relative peak power output produced during the repeated cycling sprint tests by the each participant in the scope of pre and post tests. The used sprint decrement score formula was as the follows; "Sdec% = \[1 - (total power/ideal power)\] × 100". Total power refers to accumulated PPO over the number of sprints and ideal power is defines the achieved highest PPO over the repetitions. An increase in the obtained score means that the sprint performance decreases.The total intervention period was 11 days from pre to post test. The change evaluated from pre to post test.
11 days
Secondary Outcomes (2)
Arterial Oxygen Saturation
11 days
Rate of Perceived Exertion
11 days
Study Arms (3)
3 Session Repeated Sprint Training in Normobaric Hypoxia
EXPERIMENTALHypoxia group was exposed to normobaric hypoxia equal to 3420 m (FiO2: 13.5-13.6 %).
3 Session Repeated Sprint Training in Normobaric Normoxia
SHAM COMPARATORPlacebo group was exposed to normobaric normoxia equal to 162 m (FiO2: 20.9 %) through wearing the altitude generator mask.
Control group
NO INTERVENTIONThe control group was subjected to only pre and post-test.
Interventions
Hypoxia group were exposed to normobaric hypoxia equal to 3420 m (FiO2: 13.5-13.6 %).
Placebo group were exposed to normobaric normoxia equal to 162 m (FiO2: 20.9 %) through wearing the altitude generator mask.
Eligibility Criteria
You may qualify if:
- non-smokers,
- male gender,
- those who do not have any chronic disease,
- do not use any medication,
- do not any training or accommodate above 1500 m altitude within the past 3 months,
- do not have any musculoskeletal injuries within the past 6 months and,
- train at least 3 days in a week.
You may not qualify if:
- Having a chronic or acute condition/disease during the intervention period
- Occurrence of acute respiratory illness or musculoskeletal injury during the intervention period
- Leaving the study voluntarily/on his own account
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara University
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- In this study, blinding was provided in practice by using the simulation device for the normoxia condition.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 15, 2023
First Posted
August 1, 2023
Study Start
November 1, 2022
Primary Completion
November 25, 2022
Study Completion
December 19, 2022
Last Updated
August 1, 2023
Record last verified: 2023-07